HELIOS Kliniken

Das Dreierpaket gegen Krebs (2022) Heppner HJ Journal article RHABDOID TUMOR PREDISPOSITION SYNDROME (RTPS) - FINDING EVIDENCE BY SYSTEMATIC ANALYSES (2022) Nemes K, Bens S, Johann PD, Steinbuegl M, Gruhle M, Kachanov D, Teleshova M, et al. Conference contribution INFANTS AND NEWBORNS WITH ATYPICAL TERATOID/RHABDOID TUMORS (ATRT) AND EXTRACRANIAL MALIGNANT RHABDOID TUMORS: A UNIQUE AND CHALLENGING POPULATION (2022) Nemes K, Johann PD, Steinbuegl M, Gruhle M, Bens S, Kachanov D, Teleshova M, et al. Conference contribution Update Breast Cancer 2022 Part 2 - Advanced Stage Breast Cancer (2022) Müller V, Welslau M, Lüftner D, Schütz F, Stickeler E, Fasching P, Janni W, et al. Journal article, Review article A virtual chromoendoscopy artificial intelligence system to detect endoscopic and histologic activity/remission and predict clinical outcomes in ulcerative colitis (2022) Iacucci M, Cannatelli R, Parigi TL, Nardone OM, Tontini GE, Labarile N, Buda A, et al. Journal article Impact of Time of Surgery on the Outcome after Surgical Stabilization of Rib Fractures in Severely Injured Patients with Severe Chest Trauma-A Matched-Pairs Analysis of the German Trauma Registry (2022) Becker L, Schulz-Drost S, Spering C, Franke A, Dudda M, Kamp O, Lefering R, et al. Journal article Twenty years of newborn screening for congenital adrenal hyperplasia and congenital primary hypothyroidism - experiences from the DGKED/AQUAPE study group for quality improvement in Germany (2022) Hammersen J, Bettendorf M, Bonfig W, Schoenau E, Warncke K, Eckert AJ, Fricke-Otto S, et al. Journal article Carotid Ultrasound Boundary Study (CUBS): Technical considerations on an open multi-center analysis of computerized measurement systems for intima-media thickness measurement on common carotid artery longitudinal B-mode ultrasound scans (2022) Meiburger KM, Marzola F, Zahnd G, Faita F, Loizou CP, Laine N, Carvalho C, et al. Journal article Herausforderung kognitive Einschränkung und Demenz (2022) Heppner HJ Journal article Safety interim analysis (SIA) of the phase III postneoadjuvant SASCIA study evaluating sacituzumab govitecan (SG) in patients with primary HER2-negative breast cancer (BC) at high relapse risk after neoadjuvant treatment (2022) Marme F, Hanusch C, Furlanetto J, Morris P, Link T, Denkert C, Fasching P, et al. Conference contribution